Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MIT's smart pillbox targets TB

04.03.2008
Tuberculosis has long been eradicated from the world's industrialized nations but continues to take a terrible toll in a few poor, rural regions of Asia and Africa. Every year, 10 million new cases are diagnosed and two million people die of the disease.

It's not that new treatments are needed--medical science long ago figured out how to cure tuberculosis using a cocktail of antibiotics.

The problem is getting the medicine to the people who need it and, most difficult, making sure they follow the six-month regimen of daily doses.

Failure to follow the regimen not only leads to likely death of that patient, but fosters the development of antibiotic-resistant strains of the disease. "The problem is, how do you get people to take this complex regimen," says Manish Bhardwaj, a doctoral student in the Department of Electrical Engineering and Computer Science who works in the Microsystems Technology Laboratories.

After a year of hard work and about eight revisions, Bhardwaj and a team of collaborators think they may have found the answer. It's a high-tech solution in a simple, inexpensive and easy-to-use -package.

The first part of the two-component system is a kind of "smart"
pillbox, called the uBox. It has 14 chambers that can each be loaded with several pills, which it dispenses from one chamber per day. To alert the patient that it's time to take the medicine, the box flashes its lights and sounds a buzzer. When the compartment is opened, the uBox records the exact time and prevents double-dosing by refusing to open again until the next treatment is due.

After two weeks, a health care worker reloads the box and digitally records and transmits the information stored in it. Doctors and public health services can then get complete data on compliance, patient by patient, in almost real time, instead of having to wait until the end of the six-month treatment.

"How do you know if pills are getting to the patients or if patients are taking them? Today, there's no good way of doing this," Bhardwaj says. If people fail to take all their pills, "it is possible to do harm by treatment that doesn't have good adherence." Missing medication can lead to the development of resistant strains, which can then be spread by that noncompliant patient. "The people they infect have no chance." Today, less than half of the patients that start the regimen successfully complete it.

"We want to make sure the worker is motivated," Bhardwaj says, and at present there's no way to tell which workers are diligent about making the calls and which ones may skip some of their appointed -visits. Accordingly, the uBox has an additional feature: a receptacle for a tiny key, like a headphone plug, which is carried by the visiting health care worker. At each visit the worker inserts the key, thus recording the fact that the patient really has been visited--another important gauge of compliance.

The second part of the group's new system is a cell phone, called the uPhone. By using special software, health care workers can record a patient's temperature, weight, and answers to a list of questions related to symptoms, which adds to the set of detailed patient data analyzed by doctors monitoring the study.

By looking at patterns of effects, the doctors can tell which field workers are achieving the best adherence rates with their patients and find out just what it is that those people are doing right. They can then be recruited to train additional workers.

Bhardwaj has been working with MIT alumni Goutam Reddy and Sara Cinnamon on the engineering and electronics of the pillbox, doctoral student Bill Thies and alumnus Pallavi Kaushik on the uPhone software, and MIT seniors Oliver Venn and Jessica Leon on fundraising and logistics.

Bhardwaj and Thiess went to Bihar province this January to begin their first field test of the product, conducting a training session for 22 workers who will, in turn, train the field workers to distribute the pillboxes in the field. In late April Bhardwaj will return to Bihar to train workers at two new sites. The first actual field test with 100 of the boxes and 10 cell phones should start in mid-May.

If all goes well, a second round of testing, using 1,000 uBoxes, is set to begin. After that, it all depends on the results--and on the ability to raise funds for future deployment. Health officials in India are already keenly interested in this test, and Bhardwaj is about to meet with representatives of the Bill & Melinda Gates Foundation to discuss possible collaboration and support.

The Ven. Tenzin Priyadarshi, MIT's Buddhist chaplain, helped to get the project started and says, "I am hopeful that the uBox-uPhone project will revolutionize the way we understand and provide health care in rural areas of the world."

While Bhardwaj is proud of the product his team developed, he is not proprietary about it. "We hope to make the uBox and the uPhone the standard of treatment in Bihar. We worked very hard to make something very simple and elegant," he says. "But we'd be delighted if someone beats us to it and builds a uBox cheaper. We hope other people will copy us."

Written by David Chandler, MIT News Office

Elizabeth A. Thomson | MIT News Office
Further information:
http://www.mit.edu

More articles from Health and Medicine:

nachricht Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University

nachricht Direct conversion of non-neuronal cells into nerve cells
03.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Microscopic trampoline may help create networks of quantum computers

17.07.2018 | Information Technology

In borophene, boundaries are no barrier

17.07.2018 | Materials Sciences

The role of Sodium for the Enhancement of Solar Cells

17.07.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>